trade policy
How Trump's tariffs could raise health care costs
President Trump on Saturday ordered import taxes on goods from Canada, China, and Mexico, though he later paused the levies on Canada and Mexico to give the countries time to negotiate. If they do go into effect, the tariffs could quickly raise costs for consumers, especially in health care, John Wilkerson reports.
China is a large and ever-growing producer of pharmaceutical ingredients, and prices could go up for finished drugs if costs for their ingredients increase. Mexico is the top source of medical devices used in the U.S., according to industry group AdvaMed.
Hospitals also could feel the impact. They rely on imports for many everyday supplies, such as gowns, gloves, and syringes. Big-ticket items like CT scanners and X-ray equipment also are often imported. Read more.
public health
CDC advisers press on data disappearance
Top CDC advisers are asking the agency's acting director to explain the abrupt removal of information and data from the agency's websites, and demanding to know when it will be restored, STAT's Usha Lee McFarling reported this weekend.
In a sharply worded letter sent Saturday, the advisory board asked CDC's acting director about the rationale and legality of removing databases on sexual orientation, HIV, social vulnerability indexes, and information about the agency's advisory panel on vaccines.
Some of those pages have been restored. Others haven't. Atop the CDC's website, a light yellow banner now states: "CDC's website is being modified to comply with President Trump's Executive Orders." More from Usha.
research policy
Nobel laureates rally against Trump attacks on science
Some of the country's most acclaimed scientists are fighting back against the "unprecedented" approach the second Trump administration is taking to scientific and medical research, STAT's Megan Molteni reports.
Megan reached out to two dozen of the nation's top life scientists, including 17 Nobel laureates, about the recent freeze on communications, pause on new research, and a host of policies to restrict gender-affirming care and diversity-driven studies.
"Science should not have a political litmus test" said one laureate. More from Megan's reporting.
No comments